A team from Takeda Pharmaceutical has developed a new model for monitoring bioreactors that could speed up process development. The scientists used Lonza’s Modular Automated Sampling Technology (MAST) ...
In its collective efforts to develop new drugs, the pharmaceuticals industry is making increasing use of biotechnology based on the application of natural biological transformation processes. One of ...
The Modular Automated Sampling Technology platform allows sampling of bioreactors. Unlike in the chemical and food industries, and even in small-molecule pharmaceutical manufacturing, which have ...
Pfizer, Eli Lilly, and several other pharmaceutical companies are participating in the development of automated sampling technology and associated software that improve process control and reduce ...
In its collective efforts to develop new drugs, the pharmaceuticals industry is making increasing use of biotechnology based on the application of natural biological transformation processes. One of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback